 Richard Reisdorph
Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 11 | 2025 | 679 | 1.340 |
Why?
| | Mass Spectrometry | 10 | 2025 | 739 | 1.050 |
Why?
| | Research | 2 | 2018 | 449 | 0.890 |
Why?
| | Proteomics | 10 | 2025 | 1108 | 0.820 |
Why?
| | Proteome | 6 | 2025 | 472 | 0.810 |
Why?
| | Phosphopeptides | 1 | 2018 | 20 | 0.590 |
Why?
| | Aldehyde Dehydrogenase | 4 | 2006 | 100 | 0.590 |
Why?
| | Peptide Mapping | 1 | 2018 | 64 | 0.590 |
Why?
| | Metabolome | 2 | 2020 | 350 | 0.570 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2006 | 284 | 0.570 |
Why?
| | Tyrosine | 1 | 2018 | 222 | 0.560 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2018 | 429 | 0.470 |
Why?
| | Lung | 2 | 2018 | 4067 | 0.450 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 596 | 0.450 |
Why?
| | Acidosis, Lactic | 2 | 2024 | 46 | 0.440 |
Why?
| | Chromatography, Liquid | 7 | 2025 | 432 | 0.430 |
Why?
| | Chromatography, High Pressure Liquid | 6 | 2025 | 597 | 0.420 |
Why?
| | Cysteine | 2 | 2024 | 205 | 0.390 |
Why?
| | Sulfhydryl Compounds | 2 | 2025 | 191 | 0.380 |
Why?
| | Bronchoalveolar Lavage Fluid | 5 | 2018 | 654 | 0.350 |
Why?
| | Mitochondrial Proteins | 2 | 2025 | 256 | 0.340 |
Why?
| | Tandem Mass Spectrometry | 6 | 2024 | 532 | 0.330 |
Why?
| | Ethanol | 3 | 2024 | 608 | 0.310 |
Why?
| | Methylcholanthrene | 2 | 2006 | 22 | 0.300 |
Why?
| | Analgesia | 1 | 2010 | 94 | 0.300 |
Why?
| | Cardiomyopathies | 2 | 2024 | 350 | 0.290 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.290 |
Why?
| | Seafood | 2 | 2025 | 27 | 0.290 |
Why?
| | Lysine | 3 | 2024 | 294 | 0.270 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2024 | 93 | 0.250 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 363 | 0.250 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2025 | 19 | 0.240 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2025 | 4 | 0.240 |
Why?
| | Food Analysis | 1 | 2025 | 26 | 0.240 |
Why?
| | Leigh Disease | 1 | 2025 | 21 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.230 |
Why?
| | Tea | 1 | 2025 | 21 | 0.230 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 8 | 0.230 |
Why?
| | Sirtuin 3 | 2 | 2023 | 61 | 0.230 |
Why?
| | Oxidative Phosphorylation | 1 | 2025 | 193 | 0.220 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.220 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.220 |
Why?
| | Paraffin Embedding | 1 | 2024 | 32 | 0.220 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 26 | 0.220 |
Why?
| | Formaldehyde | 1 | 2024 | 63 | 0.220 |
Why?
| | Kidney Tubules, Proximal | 1 | 2025 | 127 | 0.220 |
Why?
| | Animals | 26 | 2025 | 36862 | 0.220 |
Why?
| | Saccharum | 1 | 2025 | 77 | 0.210 |
Why?
| | Silicon Dioxide | 1 | 2025 | 116 | 0.210 |
Why?
| | Niacinamide | 1 | 2024 | 79 | 0.210 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 30 | 0.210 |
Why?
| | Corneal Injuries | 1 | 2024 | 44 | 0.210 |
Why?
| | Mitochondria | 4 | 2025 | 947 | 0.200 |
Why?
| | Lipids | 2 | 2017 | 666 | 0.200 |
Why?
| | Cholesterol | 2 | 2023 | 410 | 0.190 |
Why?
| | Acylation | 2 | 2019 | 31 | 0.190 |
Why?
| | Mustard Gas | 1 | 2024 | 103 | 0.190 |
Why?
| | Nervous System Diseases | 1 | 2025 | 265 | 0.190 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 114 | 0.190 |
Why?
| | Cell Hypoxia | 2 | 2003 | 226 | 0.190 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 372 | 0.180 |
Why?
| | Ion Mobility Spectrometry | 2 | 2017 | 5 | 0.180 |
Why?
| | Bronchoalveolar Lavage | 2 | 2018 | 93 | 0.180 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.170 |
Why?
| | Liquid-Liquid Extraction | 2 | 2018 | 14 | 0.170 |
Why?
| | Diabetic Nephropathies | 1 | 2024 | 294 | 0.170 |
Why?
| | Biomarkers | 6 | 2024 | 4164 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 84 | 0.160 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 147 | 0.160 |
Why?
| | Succinic Acid | 1 | 2019 | 39 | 0.160 |
Why?
| | Myofibrils | 1 | 2019 | 49 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 182 | 0.160 |
Why?
| | Mice | 15 | 2025 | 17774 | 0.160 |
Why?
| | Acetylation | 3 | 2024 | 248 | 0.150 |
Why?
| | Nanoparticles | 1 | 2025 | 484 | 0.150 |
Why?
| | Liposomes | 1 | 2020 | 220 | 0.150 |
Why?
| | Cornea | 3 | 2024 | 137 | 0.150 |
Why?
| | Organic Chemicals | 1 | 2020 | 126 | 0.150 |
Why?
| | Food | 1 | 2020 | 160 | 0.150 |
Why?
| | Trypsin | 1 | 2018 | 77 | 0.150 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 612 | 0.150 |
Why?
| | Humans | 28 | 2025 | 137294 | 0.150 |
Why?
| | Hypoxia | 2 | 2006 | 1111 | 0.140 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 263 | 0.140 |
Why?
| | Autoantigens | 2 | 2011 | 428 | 0.140 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2016 | 1095 | 0.140 |
Why?
| | DNA-Binding Proteins | 2 | 2003 | 1501 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 698 | 0.130 |
Why?
| | Receptors, Aryl Hydrocarbon | 3 | 2003 | 56 | 0.130 |
Why?
| | Workflow | 1 | 2018 | 166 | 0.130 |
Why?
| | Oxidation-Reduction | 3 | 2025 | 1069 | 0.130 |
Why?
| | Epitopes | 2 | 2016 | 480 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2018 | 731 | 0.120 |
Why?
| | Major Histocompatibility Complex | 1 | 2016 | 227 | 0.120 |
Why?
| | Phosphorylation | 2 | 2018 | 1759 | 0.120 |
Why?
| | C-Peptide | 1 | 2016 | 163 | 0.120 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2016 | 368 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 337 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 194 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 1002 | 0.110 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2014 | 132 | 0.110 |
Why?
| | Xenobiotics | 2 | 2006 | 32 | 0.110 |
Why?
| | Mutation | 1 | 2025 | 3956 | 0.110 |
Why?
| | Mutation, Missense | 2 | 2025 | 338 | 0.100 |
Why?
| | Galectins | 1 | 2013 | 24 | 0.100 |
Why?
| | Oxidative Stress | 3 | 2025 | 1315 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 2 | 2024 | 467 | 0.090 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 149 | 0.090 |
Why?
| | Software | 2 | 2013 | 667 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2016 | 3710 | 0.090 |
Why?
| | Pulmonary Emphysema | 1 | 2014 | 290 | 0.090 |
Why?
| | Hypersensitivity | 2 | 2017 | 257 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2113 | 0.090 |
Why?
| | Male | 12 | 2025 | 67560 | 0.090 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2011 | 46 | 0.090 |
Why?
| | Reactive Oxygen Species | 2 | 2025 | 622 | 0.090 |
Why?
| | Asthma | 2 | 2017 | 2293 | 0.080 |
Why?
| | Liver Neoplasms, Experimental | 2 | 2001 | 31 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 42 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 445 | 0.080 |
Why?
| | Rats | 3 | 2006 | 5639 | 0.080 |
Why?
| | Computational Biology | 1 | 2013 | 646 | 0.080 |
Why?
| | Protein C | 1 | 2009 | 59 | 0.080 |
Why?
| | Epithelium, Corneal | 2 | 1999 | 41 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2001 | 954 | 0.070 |
Why?
| | Cell Line | 3 | 2025 | 2841 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2006 | 1095 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2013 | 4197 | 0.070 |
Why?
| | Urinalysis | 2 | 2020 | 77 | 0.070 |
Why?
| | Down-Regulation | 2 | 2001 | 658 | 0.070 |
Why?
| | Mice, Inbred NOD | 3 | 2016 | 601 | 0.060 |
Why?
| | Luciferases | 1 | 2006 | 150 | 0.060 |
Why?
| | Response Elements | 1 | 2006 | 91 | 0.060 |
Why?
| | Smoking | 1 | 2014 | 1634 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 405 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2234 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3414 | 0.060 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 2147 | 0.060 |
Why?
| | Genes, Reporter | 1 | 2006 | 269 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 707 | 0.060 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 886 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Electron Transport Complex IV | 1 | 2025 | 59 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2006 | 2839 | 0.060 |
Why?
| | Germ-Free Life | 1 | 2025 | 34 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 61 | 0.060 |
Why?
| | Islets of Langerhans | 1 | 2011 | 803 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.060 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2003 | 17 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2024 | 36 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5753 | 0.050 |
Why?
| | Transcription Factors | 2 | 2003 | 1720 | 0.050 |
Why?
| | Introns | 1 | 2024 | 256 | 0.050 |
Why?
| | Age of Onset | 1 | 2025 | 519 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 394 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2003 | 92 | 0.050 |
Why?
| | Actin Cytoskeleton | 1 | 2024 | 101 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 344 | 0.050 |
Why?
| | Mice, Knockout | 3 | 2019 | 3009 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 200 | 0.050 |
Why?
| | Click Chemistry | 1 | 2023 | 49 | 0.050 |
Why?
| | Female | 7 | 2025 | 73052 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1354 | 0.050 |
Why?
| | Rabbits | 1 | 2024 | 793 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2025 | 549 | 0.050 |
Why?
| | Alleles | 1 | 2025 | 892 | 0.050 |
Why?
| | Caenorhabditis elegans | 1 | 2025 | 305 | 0.050 |
Why?
| | Feces | 1 | 2025 | 480 | 0.050 |
Why?
| | Actins | 1 | 2024 | 416 | 0.050 |
Why?
| | Dexamethasone | 1 | 2024 | 377 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 327 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 17 | 0.040 |
Why?
| | Sphingomyelins | 1 | 2020 | 33 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 659 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 514 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 57 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 33310 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 77 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 91 | 0.040 |
Why?
| | Up-Regulation | 1 | 2003 | 844 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 112 | 0.040 |
Why?
| | Cell Cycle | 1 | 2003 | 601 | 0.040 |
Why?
| | Peptides | 2 | 2016 | 982 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 993 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 66 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 151 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 99 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4284 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 536 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2003 | 613 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 321 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 180 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 231 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 485 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2025 | 920 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 238 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 40 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.040 |
Why?
| | Species Specificity | 1 | 2020 | 585 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2016 | 2904 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1998 | 121 | 0.040 |
Why?
| | Cobalt | 1 | 1998 | 52 | 0.040 |
Why?
| | Critical Illness | 1 | 2024 | 808 | 0.040 |
Why?
| | Bacteria | 1 | 2025 | 858 | 0.040 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 5 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 562 | 0.030 |
Why?
| | Binding Sites | 1 | 2020 | 1309 | 0.030 |
Why?
| | Glycerophospholipids | 1 | 2017 | 34 | 0.030 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 79 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 417 | 0.030 |
Why?
| | Proline | 1 | 2017 | 79 | 0.030 |
Why?
| | Sphingolipids | 1 | 2017 | 77 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 814 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1467 | 0.030 |
Why?
| | Germ Cells | 1 | 2016 | 63 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 160 | 0.030 |
Why?
| | Liver | 1 | 2024 | 1941 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1275 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1501 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 266 | 0.030 |
Why?
| | Arginine | 1 | 2017 | 271 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 313 | 0.030 |
Why?
| | Solid Phase Extraction | 1 | 2014 | 25 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 2225 | 0.030 |
Why?
| | Adult | 3 | 2025 | 37724 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 94 | 0.030 |
Why?
| | Blood Chemical Analysis | 1 | 2014 | 99 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1588 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2016 | 362 | 0.030 |
Why?
| | Education | 1 | 2013 | 107 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 23 | 0.030 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2013 | 30 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2024 | 6054 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 83 | 0.020 |
Why?
| | Blood Pressure | 1 | 2020 | 1776 | 0.020 |
Why?
| | Interleukin-15 | 1 | 2013 | 97 | 0.020 |
Why?
| | Interleukin-12 | 1 | 2013 | 121 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2013 | 225 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1864 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3283 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 156 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11080 | 0.020 |
Why?
| | Infant | 1 | 2024 | 9451 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 55 | 0.020 |
Why?
| | Signal Transduction | 1 | 2003 | 5078 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 226 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 114 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 35 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 53 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 113 | 0.020 |
Why?
| | Fibrinogen | 1 | 2009 | 168 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 108 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1998 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1355 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 406 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 252 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 693 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 983 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2013 | 1163 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1692 | 0.020 |
Why?
| | Child | 1 | 2025 | 21999 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 886 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1946 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 75 | 0.010 |
Why?
| | Chickens | 1 | 2003 | 191 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 271 | 0.010 |
Why?
| | Proteins | 1 | 2009 | 1012 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 767 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 947 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 425 | 0.010 |
Why?
| | Eye Proteins | 1 | 1999 | 92 | 0.010 |
Why?
| | Genomics | 1 | 2003 | 792 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2003 | 1399 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2003 | 1774 | 0.010 |
Why?
| | Young Adult | 1 | 2009 | 13163 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|